Wedbush initiated coverage on Impel NeuroPharma with a new price target
$IMPL
Biotechnology: Pharmaceutical Preparations
Health Care
Wedbush initiated coverage of Impel NeuroPharma with a rating of Outperform and set a new price target of $21.00
Save time and jump to the most important pieces.